[{"address1": "National Innovation Centre", "address2": "4 Cornwallis Street Eveleigh", "city": "Sydney", "state": "NSW", "zip": "2015", "country": "Australia", "phone": "61 2 9209 4037", "fax": "61 2 9209 4037", "website": "https://www.claritypharmaceuticals.com", "industry": "Biotechnology", "industryKey": "biotechnology", "industryDisp": "Biotechnology", "sector": "Healthcare", "sectorKey": "healthcare", "sectorDisp": "Healthcare", "longBusinessSummary": "Clarity Pharmaceuticals Ltd, a clinical stage radiopharmaceutical company, engages in research and development of radiopharmaceuticals products for oncology in Australia and the United States. The company's lead product is SAR-bisPSMA, a theranostic radiopharmaceutical for the treatment of Prostate Specific Membrane Antigen (PSMA) cancer. It also develops SAR-Bombesin, a pan cancer theranostic radiopharmaceutical to treat prostate, breast, ovarian, urinary, small cell lung cancer, as well as glioblastoma and gastrointestinal stromal tumours; and SARTATE, a theranostic radiopharmaceutical for the treatment of somatostatin receptor 2 (SSTR2) cancer. The company was incorporated in 2010 and is based in Sydney, Australia.", "fullTimeEmployees": 69, "companyOfficers": [{"maxAge": 1, "name": "Dr. Alan John Taylor Ph.D.", "title": "Executive Chairman", "fiscalYear": 2025, "totalPay": 1059347, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Michelle  Parker", "title": "CEO, MD & Executive Director", "fiscalYear": 2025, "totalPay": 552742, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. David K. Green BEc., CA", "title": "Chief Financial Officer", "fiscalYear": 2025, "totalPay": 342544, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Colin David Biggin Ph.D.", "title": "COO & Non-Independent Executive Director", "fiscalYear": 2025, "totalPay": 525296, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Matthew  Harris BSc., M.B.A., Ph.D.", "title": "Chief Scientific Officer", "fiscalYear": 2025, "totalPay": 135150, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Lisa  Sadetskaya", "title": "Director of Corporate Communications.", "fiscalYear": 2025, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Mary  Bennett", "title": "Head of People & Culture", "fiscalYear": 2025, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Shaemus  Gleason", "title": "Executive Vice President of Operations", "fiscalYear": 2025, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Othon  Gervasio", "title": "Chief Medical Officer", "fiscalYear": 2025, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Eva  Lengyelova", "title": "Executive Vice President of Clinical Development", "fiscalYear": 2025, "exercisedValue": 0, "unexercisedValue": 0}], "auditRisk": 9, "boardRisk": 10, "compensationRisk": 8, "shareHolderRightsRisk": 1, "overallRisk": 10, "governanceEpochDate": 1769904000, "compensationAsOfEpochDate": 1767139200, "executiveTeam": [], "maxAge": 86400, "priceHint": 4, "previousClose": 2.09, "open": 2.05, "dayLow": 2.05, "dayHigh": 2.05, "regularMarketPreviousClose": 2.09, "regularMarketOpen": 2.05, "regularMarketDayLow": 2.05, "regularMarketDayHigh": 2.05, "payoutRatio": 0.0, "beta": 1.244, "volume": 100, "regularMarketVolume": 100, "averageVolume": 2376, "averageVolume10days": 1890, "averageDailyVolume10Day": 1890, "bid": 1.99, "ask": 2.2, "bidSize": 500, "askSize": 400, "marketCap": 765625920, "fiftyTwoWeekLow": 0.842, "fiftyTwoWeekHigh": 3.6, "allTimeHigh": 6.398, "allTimeLow": 0.842, "priceToSalesTrailing12Months": 80.90878, "fiftyDayAverage": 2.2402, "twoHundredDayAverage": 2.24588, "trailingAnnualDividendRate": 0.0, "trailingAnnualDividendYield": 0.0, "currency": "USD", "tradeable": false, "enterpriseValue": 574898432, "profitMargins": 0.0, "floatShares": 232317890, "sharesOutstanding": 372030071, "heldPercentInsiders": 0.21305001, "heldPercentInstitutions": 0.23604, "impliedSharesOutstanding": 373476077, "bookValue": 0.19432274, "priceToBook": 10.54946, "lastFiscalYearEnd": 1751241600, "nextFiscalYearEnd": 1782777600, "mostRecentQuarter": 1751241600, "netIncomeToCommon": -64295436, "trailingEps": -0.14, "enterpriseToRevenue": 60.753, "enterpriseToEbitda": -8.343, "52WeekChange": -0.19921875, "SandP52WeekChange": 0.120657206, "quoteType": "EQUITY", "currentPrice": 2.05, "recommendationKey": "none", "totalCash": 84118352, "totalCashPerShare": 0.262, "ebitda": -68908944, "totalDebt": 0, "quickRatio": 9.077, "currentRatio": 9.693, "totalRevenue": 9462828, "revenuePerShare": 0.03, "returnOnAssets": -0.33764, "returnOnEquity": -0.54366, "grossProfits": 9462828, "freeCashflow": -33697940, "operatingCashflow": -54769024, "revenueGrowth": -0.216, "grossMargins": 1.0, "ebitdaMargins": 0.0, "operatingMargins": -8.231791, "financialCurrency": "AUD", "symbol": "CLRPF", "language": "en-US", "region": "US", "typeDisp": "Equity", "quoteSourceName": "Delayed Quote", "triggerable": false, "customPriceAlertConfidence": "LOW", "shortName": "Clarity Pharmaceuticals Ltd.", "longName": "Clarity Pharmaceuticals Ltd", "marketState": "CLOSED", "corporateActions": [], "regularMarketTime": 1770325200, "exchange": "PNK", "messageBoardId": "finmb_263530964", "exchangeTimezoneName": "America/New_York", "exchangeTimezoneShortName": "EST", "gmtOffSetMilliseconds": -18000000, "market": "us_market", "esgPopulated": false, "regularMarketChangePercent": -1.9138739, "regularMarketPrice": 2.05, "hasPrePostMarketData": false, "firstTradeDateMilliseconds": 1723728600000, "regularMarketChange": -0.03999996, "regularMarketDayRange": "2.05 - 2.05", "fullExchangeName": "OTC Markets OTCPK", "averageDailyVolume3Month": 2376, "fiftyTwoWeekLowChange": 1.208, "fiftyTwoWeekLowChangePercent": 1.4346793, "fiftyTwoWeekRange": "0.842 - 3.6", "fiftyTwoWeekHighChange": -1.55, "fiftyTwoWeekHighChangePercent": -0.43055555, "fiftyTwoWeekChangePercent": -19.921875, "earningsTimestampStart": 1755514740, "earningsTimestampEnd": 1756728000, "isEarningsDateEstimate": true, "epsTrailingTwelveMonths": -0.14, "fiftyDayAverageChange": -0.19020009, "fiftyDayAverageChangePercent": -0.08490317, "twoHundredDayAverageChange": -0.19587994, "twoHundredDayAverageChangePercent": -0.08721746, "sourceInterval": 15, "exchangeDataDelayedBy": 0, "cryptoTradeable": false, "displayName": "Clarity Pharmaceuticals", "trailingPegRatio": null, "__fetch_time": "2026-02-07"}]